Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-27 @ 11:08 AM
Study NCT ID:
NCT00800904
Status:
COMPLETED
Last Update Posted:
2010-12-03
First Post:
2008-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand
Status:
COMPLETED
Status Verified Date:
2010-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: